US FDA asks drugmakers to remove warnings from hormone therapy

Source: Reuters

(Reuters) -The U.S. Food and Drug Administration has initiated the removal of the agency's ​strictest "black box" warnings from hormone therapies given ‌to women to treat menopause symptoms, according to the health regulator's website.

The ‌FDA's decision follows a comprehensive review of scientific literature, an expert panel in July, and a public comment period.

The agency said it is working with drug manufacturers to update language in product labeling ⁠to remove references to ‌risks of cardiovascular disease, breast cancer, and probable dementia.

Hormone replacement therapy for menopause replenishes the hormones, ‍primarily estrogen, that decline with menopause to relieve symptoms like hot flashes and vaginal dryness.

Read more: https://www.yahoo.com/news/articles/us-fda-chief-makary-asks-155210161.html